VUGENE
VUGENE is a biomedical data science company that specializes in the analysis and integration of multi-omics data to accelerate scientific research and drive innovation. They offer services in genomics, transcriptomics, single-cell approaches, epigenomics, metabolomics, and proteomics, leveraging machine learning and artificial intelligence for predictive modeling and pattern recognition. Their value proposition lies in transforming complex omics data into functional discoveries, saving time, reducing complexity, and empowering data-driven decisions through expert guidance and effective collaboration. They serve individual principal investigators, research institutions, biotech companies, pharmaceutical companies, and contract research organizations, aiming to advance precision medicine, disease research, and therapeutics development.
VUGENE
VUGENE is a biomedical data science company that specializes in the analysis and integration of multi-omics data to accelerate scientific research and drive innovation. They offer services in genomics, transcriptomics, single-cell approaches, epigenomics, metabolomics, and proteomics, leveraging machine learning and artificial intelligence for predictive modeling and pattern recognition. Their value proposition lies in transforming complex omics data into functional discoveries, saving time, reducing complexity, and empowering data-driven decisions through expert guidance and effective collaboration. They serve individual principal investigators, research institutions, biotech companies, pharmaceutical companies, and contract research organizations, aiming to advance precision medicine, disease research, and therapeutics development.
TL;DR
What they do: Multi-omics bioinformatics and ML/AI-driven analysis for biomedical research
Founded: 2021
Headquarters: Lithuania (Vilnius)
Latest funding: €1M seed (May 5, 2025) led by Superhero Capital
Related Companies
| Company |
|---|
 |
 |
 |
 |
 |
Company Overview
Problem Domain
Multi-omics data analysis and interpretation for biomedical research and drug discovery.
Founded
2021
Industry
Biotechnology
Tech Stack
Funding Track Record
€1,000,000
Participation from NGL Ventures, Coinvest Capital and angel investors
Investor Signal
“Led by Superhero Capital with participation from NGL Ventures, Coinvest Capital and angels”